Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. [electronic resource]
Producer: 20100720Description: 3219-26 p. digitalISSN:- 1527-7755
- Aged
- Antimetabolites, Antineoplastic -- therapeutic use
- Biomarkers
- Chemotherapy, Adjuvant
- Colonic Neoplasms -- drug therapy
- Combined Modality Therapy
- DNA Mismatch Repair
- Disease-Free Survival
- Drug Resistance, Neoplasm -- genetics
- Female
- Fluorouracil -- administration & dosage
- Humans
- Male
- Middle Aged
- Prognosis
- Randomized Controlled Trials as Topic
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Validation Study
There are no comments on this title.
Log in to your account to post a comment.